Bio-Techne to Present at Upcoming Investor Conferences
Bio-Techne (NASDAQ: TECH) will present at four investor conferences in November 2025. Scheduled presentations:
- UBS Global Healthcare — November 10, 2025 at 10:15 AM ET
- Stifel Healthcare — November 11, 2025 at 9:20 AM ET
- Stephens Investment — November 18, 2025 at 8:00 AM CT
- Jefferies Global Healthcare — November 20, 2025 at 12:30 PM GMT
A live webcast will be available via the company's Investor Relations Calendar at https://investors.bio-techne.com/ir-calendar.
Bio-Techne (NASDAQ: TECH) presenterà a quattro conferenze di investimento a novembre 2025. Presentazioni in programma:
- UBS Global Healthcare — 10 novembre 2025 alle 10:15 AM ET
- Stifel Healthcare — 11 novembre 2025 alle 9:20 AM ET
- Stephens Investment — 18 novembre 2025 alle 8:00 AM CT
- Jefferies Global Healthcare — 20 novembre 2025 alle 12:30 PM GMT
Una webcast in diretta sarà disponibile tramite il Investor Relations Calendar dell'azienda all'indirizzo https://investors.bio-techne.com/ir-calendar.
Bio-Techne (NASDAQ: TECH) participará en cuatro conferencias para inversionistas en noviembre de 2025. Presentaciones programadas:
- UBS Global Healthcare — 10 de noviembre de 2025 a las 10:15 AM ET
- Stifel Healthcare — 11 de noviembre de 2025 a las 9:20 AM ET
- Stephens Investment — 18 de noviembre de 2025 a las 8:00 AM CT
- Jefferies Global Healthcare — 20 de noviembre de 2025 a las 12:30 PM GMT
Una webcast en vivo estará disponible a través del Investor Relations Calendar de la empresa en https://investors.bio-techne.com/ir-calendar.
Bio-Techne (NASDAQ: TECH)는 2025년 11월에 네 차례의 투자자 컨퍼런스에 발표할 예정이다. 예정된 발표:
- UBS Global Healthcare — 2025년 11월 10일 10:15 AM ET
- Stifel Healthcare — 2025년 11월 11일 9:20 AM ET
- Stephens Investment — 2025년 11월 18일 8:00 AM CT
- Jefferies Global Healthcare — 2025년 11월 20일 12:30 PM GMT
라이브 웹캐스트는 회사의 Investor Relations Calendar를 통해 https://investors.bio-techne.com/ir-calendar에서 이용 가능하다.
Bio-Techne (NASDAQ: TECH) participera à quatre conférences investisseurs en novembre 2025. Présentations prévues :
- UBS Global Healthcare — le 10 novembre 2025 à 10:15 AM ET
- Stifel Healthcare — le 11 novembre 2025 à 9:20 AM ET
- Stephens Investment — le 18 novembre 2025 à 8:00 AM CT
- Jefferies Global Healthcare — le 20 novembre 2025 à 12:30 PM GMT
Une diffusion en direct sera disponible via le Investor Relations Calendar de l'entreprise à l'adresse https://investors.bio-techne.com/ir-calendar.
Bio-Techne (NASDAQ: TECH) wird im November 2025 an vier Investorenkonferenzen teilnehmen. Geplante Präsentationen:
- UBS Global Healthcare — 10. November 2025 um 10:15 Uhr ET
- Stifel Healthcare — 11. November 2025 um 9:20 Uhr ET
- Stephens Investment — 18. November 2025 um 8:00 Uhr CT
- Jefferies Global Healthcare — 20. November 2025 um 12:30 Uhr GMT
Eine Live-Webcast wird über den Investor Relations Calendar des Unternehmens unter https://investors.bio-techne.com/ir-calendar zur Verfügung stehen.
Bio-Techne (NASDAQ: TECH) ستشارك في أربع مؤتمرات للمستثمرين في نوفمبر 2025. العروض المجدولة:
- UBS Global Healthcare — 10 نوفمبر 2025 الساعة 10:15 صباحاً بتوقيت شرق الولايات المتحدة
- Stifel Healthcare — 11 نوفمبر 2025 الساعة 9:20 صباحاً بتوقيت شرق الولايات المتحدة
- Stephens Investment — 18 نوفمبر 2025 الساعة 8:00 صباحاً بتوقيت وسط الولايات المتحدة
- Jefferies Global Healthcare — 20 نوفمبر 2025 الساعة 12:30 ظهراً بتوقيت GMT
سيكون هناك بث مباشر عبر جدول علاقات المستثمرين للشركة على العنوان https://investors.bio-techne.com/ir-calendar.
- None.
- None.
UBS Global Healthcare Conference 2025
November 10, 2025
10:15 AM EST
Stifel 2025 Healthcare Conference
November 11, 2025
9:20 AM EST
Stephens Investment Conference
November 18, 2025
8:00 AM CST
Jefferies Global Healthcare Conference
November 20, 2025
12:30 PM GMT
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over
|
Contact: |
David Clair, Vice President, Investor Relations & Corporate Development |
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302605528.html
SOURCE Bio-Techne Corporation